Zydus’ Nesher Pharmaceuticals receives final approval from USFDA for Omega-3-Acid Ethyl Esters Capsules

MUMBAI, June 17: Zydus’ Nesher Pharmaceuticals, a subsidiary of Zydus Pharmaceuticals USA has received the final approval from the USFDA to market Omega-3-Acid Ethyl Esters Capsules USP (US RLD –
Lovaza Capsules), 1 gram.
Omega-3 acid ethyl esters, a type of fat found in fish oil, is used along with diet and exercise to help lower levels of a certain blood fat (triglyceride), company said in a filing with BSE.
It may also raise good cholesterol(HDL).The drug will be manufactured at Nesher Pharmaceuticals’ manufacturing facility located at St Louis, MO, USA.
The group now has 267 approvals and has so far filed over 360 ANDAs since the commencement of the filing process in FY 2003-04.